First shipment of AstraZeneca vaccine arrives amid confusion over its use for seniors

vaccine

The first doses of the Oxford-AstraZeneca COVID-19 vaccine are set to arrive in Canada today as confusion persists over who should get it.

Canada is to receive 500,000 doses of the vaccine, the third approved for use in Canada, from the Serum Institute of India.

But questions about who should receive the Oxford-AstraZeneca vaccine continue amid conflicting guidance about its use.

Health Canada last week authorized its use for all adult Canadians but the National Advisory Committee on Immunization recommended Tuesday that it not be administered to people 65 years of age or older.

The committee says there is limited data from clinical trials about how effective the Oxford-AstraZeneca vaccine is for seniors and recommends that they be given priority for the two other vaccines — Pfizer-BioNTech and Moderna — already greenlighted for use in Canada.

Both Health Canada and the committee stress no safety concerns have arisen in the clinical studies or among the millions of seniors who have received the Oxford-AstraZeneca vaccine in other countries.